Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

194
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
194
Cancer Survival Analysis01:21

Cancer Survival Analysis

529
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
529
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

518
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
518
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

405
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational Design, Synthesis, Molecular Docking, and Evaluation of Thioridazine-modified Tetrahydrocarbazole Derivatives as Antitubercular Agents.

Recent advances in anti-infective drug discovery·2026
Same author

Integrated machine learning, molecular docking, and molecular dynamics simulations for in silico identification of GSK3β inhibitors for Alzheimer's disease.

Scientific reports·2026
Same author

Neurodegenerative Disease Molecular Therapeutics based on Structural Activity Connections of Microglia Activation and Priming: A Comprehensive Review.

Current topics in medicinal chemistry·2026
Same author

In Silico Prediction, Characterization, and Pre-clinical Appraisal of the Neuroprotective Effect of the Methanolic Extract of Cassytha filiformis.

Current neurovascular research·2026
Same author

Innovative Drug Delivery Strategies for Enhanced Treatment of Antimicrobial Resistance.

Current drug delivery·2026
Same author

In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease.

Scientific reports·2026

Related Experiment Video

Updated: Nov 21, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

506

Three years mortality analysis in general surgery patients.

Dileep Kumar1, Hina Bukhari2, Shamim Qureshi3

  • 1Dr. Dileep Kumar, Associate Professor, Department of General Surgery, Ward-2, Jinnah Postgraduate Medical Center, Karachi, Pakistan.

Pakistan Journal of Medical Sciences
|January 13, 2021
PubMed
Summary

Surgical patient mortality is influenced by delayed presentation and treatment, with sepsis and gastrointestinal issues being leading causes of death. Improving patient care requires addressing these factors and enhancing critical care access.

Keywords:
ComplicationsMortalityMyocardial infarctionPatientsPulmonary embolismSepsisSurgical

More Related Videos

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
04:14

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

Published on: September 22, 2023

736

Related Experiment Videos

Last Updated: Nov 21, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

506
Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
04:14

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

Published on: September 22, 2023

736

Area of Science:

  • Medical research
  • Surgical outcomes
  • Public health

Background:

  • Surgical patient mortality is a key metric for healthcare quality.
  • Understanding mortality components aids in improving patient management.

Purpose of the Study:

  • To assess mortality rates within a surgical department.
  • To identify factors associated with surgical and non-surgical deaths.

Main Methods:

  • Retrospective data collection from January 2015 to December 2017.
  • Analysis of admissions, procedures, patient factors, and causes of death.
  • Evaluation of presentation time, surgical decision-making, and critical care availability.

Main Results:

  • Overall mortality rate was 5.07% (291 deaths out of 5730 admissions).
  • Leading causes included gastrointestinal issues (sepsis, peritonitis, obstruction), trauma, and malignancies.
  • Delayed patient presentation (over 5 days) and delayed surgical intervention (over 24 hours) were significant factors.
  • Lack of Intensive Care Unit/High Dependency Unit (ICU/HDU) availability contributed to 51.01% of mortality.

Conclusions:

  • Mortality patterns fluctuate, with sepsis and advanced conditions being major contributors.
  • Delayed presentation and treatment significantly impact surgical mortality.
  • Enhancing critical care infrastructure and timely interventions are crucial for reducing surgical deaths.